ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity

Detalles Bibliográficos
Autores principales: Moral, John Alec, Leung, Joanne, Rojas, Luis A., Ruan, Jennifer, Zhao, Julia, Sethna, Zachary, Ramnarain, Anita, Gasmi, Billel, Gururajan, Murali, Redmond, David, Askan, Gokce, Bhanot, Umesh, Elyada, Ela, Park, Youngkyu, Tuveson, David A., Gönen, Mithat, Leach, Steven D., Wolchok, Jedd D., DeMatteo, Ronald P., Merghoub, Taha, Balachandran, Vinod P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060130/
https://www.ncbi.nlm.nih.gov/pubmed/32076273
http://dx.doi.org/10.1038/s41586-020-2015-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060130/
https://www.ncbi.nlm.nih.gov/pubmed/32076273
http://dx.doi.org/10.1038/s41586-020-2015-4

Ejemplares similares